Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:30:37.874Z.
Calculation as of: 2026-10-06T13:30:37.874Z.
Quote observation: 2026-10-06T13:30:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c84a17f2c5c981e3cafbb97a54cdccede593a8f239875ee545639e7176ba2e68
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Atara Biotherapeutics, Inc.
Market Cap
$84.79M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.13M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.60M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$87.96M
Free Cash Flow Yield
24.64%
TTM Avg
19.27%
3Y Avg
25.95%
5Y Avg
22.72%
Market Cap
$88.21M
Free Cash Flow Yield
4.78%
TTM Avg
2.62%
3Y Avg
2.45%
5Y Avg
2.45%
Market Cap
$88.63M
Free Cash Flow Yield
N/A
TTM Avg
5.92%
3Y Avg
6.70%
5Y Avg
6.29%
Market Cap
$88.97M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.78M
Free Cash Flow Yield
N/A
TTM Avg
0.15%
3Y Avg
0.15%
5Y Avg
0.15%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $84.79M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.17M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.60M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 24.64% | 19.27% | 25.95% | 22.72% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 4.78% | 2.62% | 2.45% | 2.45% |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | N/A | 5.92% | 6.70% | 6.29% |
| Conexeu Sciences Inc. (CNXU)vs › | $88.97M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.78M | N/A | 0.15% | 0.15% | 0.15% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.83M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
